Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of British Columbia

$20,000.00

Microencapsulated bacteriophage cocktail for the targeted inhibition of Salmonella enterica in broiler chickens - Market Assessment Application

FY 2021-22

Summary
Chickens are by far the most farmed animal in Canada with ~$2.8 billion generated by Canadian chicken producers, and 500 million chicken products exported to 50 other countries annually. On the other hand, chicken is also the #1 food associated with foodborne salmonellosis, especially in recent years with growing antibiotic resistance. This has resulted in stakeholders searching for antibiotic alternatives, leaving them with limited options to tackle these pathogens. Environmentally, it is difficult to eliminate Salmonella because it is found almost everywhere throughout the poultry production chain. Even though many food safety measures are already in place, about one quarter of the chickens on the Canadian market are still found to test positive for Salmonella. We have created an effective bacteriophage treatment that can be fed to chickens on-farm to target and eliminate the Salmonella living in their digestive systems. A bacteriophage (phage) is a naturally occurring microorganism that invades and reproduces within bacteria, ultimately leading to bacterial death. Phages cannot interact with animal cells, and they are very specific to a single type of bacteria. This means that our Salmonella phages can only recognize and kill Salmonella. Phages also have a lot to offer in the food industry because they are safe to eat, they are classified as organic and clean label, they are cost competitive, and they don't affect the nutrition, quality, or sensory characteristics of food. Our innovation will have a large impact in the poultry industry because it will be the first time that we can directly reduce the burden of Salmonella in chickens leaving the farm without the use of medically important antibiotics. We predict that our treatment will cause a 90% or larger reduction in Salmonella, which will lead to a meaningful decrease on chicken products at retail.
Program
Idea to Innovation
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
571241-2022
Name nom
Wang, Siyun
Department département
Land and Food Systems, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
6102
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food microbiology
Research subject fr
Microbiologie alimentaire
Installment
inst:1
Partie
1
Nb partie
1
Application title
Microencapsulated bacteriophage cocktail for the targeted inhibition of Salmonella enterica in broiler chickens - Market Assessment Application
Keyword
NSERC
Application summary
Chickens are by far the most farmed animal in Canada with ~$2.8 billion generated by Canadian chicken producers, and 500 million chicken products exported to 50 other countries annually. On the other hand, chicken is also the #1 food associated with foodborne salmonellosis, especially in recent years with growing antibiotic resistance. This has resulted in stakeholders searching for antibiotic alternatives, leaving them with limited options to tackle these pathogens. Environmentally, it is difficult to eliminate Salmonella because it is found almost everywhere throughout the poultry production chain. Even though many food safety measures are already in place, about one quarter of the chickens on the Canadian market are still found to test positive for Salmonella. We have created an effective bacteriophage treatment that can be fed to chickens on-farm to target and eliminate the Salmonella living in their digestive systems. A bacteriophage (phage) is a naturally occurring microorganism that invades and reproduces within bacteria, ultimately leading to bacterial death. Phages cannot interact with animal cells, and they are very specific to a single type of bacteria. This means that our Salmonella phages can only recognize and kill Salmonella. Phages also have a lot to offer in the food industry because they are safe to eat, they are classified as organic and clean label, they are cost competitive, and they don't affect the nutrition, quality, or sensory characteristics of food. Our innovation will have a large impact in the poultry industry because it will be the first time that we can directly reduce the burden of Salmonella in chickens leaving the farm without the use of medically important antibiotics. We predict that our treatment will cause a 90% or larger reduction in Salmonella, which will lead to a meaningful decrease on chicken products at retail.